Growth Metrics

Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.60%
Dec 31, 2025 -12.03%
Sep 30, 2025 37.04%
Jun 30, 2025 26.57%
Mar 31, 2025 -20.77%
Dec 31, 2024 -18.96%
Sep 30, 2024 -27.68%
Jun 30, 2024 -17.34%
Mar 31, 2024 31.28%
Dec 31, 2023 -3.98%
Sep 30, 2023 85.49%
Jun 30, 2023 2.72%
Mar 31, 2023 25.13%
Dec 31, 2022 29.75%
Sep 30, 2022 4.11%
Jun 30, 2022 44.18%
Mar 31, 2022 32.82%
Dec 31, 2021 48.21%
Sep 30, 2021 96.07%
Jun 30, 2021 16.67%
Mar 31, 2021 2.61%
Dec 31, 2020 29.49%
Sep 30, 2020 -37.74%
Jun 30, 2020 220.30%
Mar 31, 2020 25.17%
Dec 31, 2019 26.35%
Sep 30, 2019 -5.05%
Jun 30, 2019 -22.18%
Mar 31, 2019 171.16%
Dec 31, 2018 37.26%
Sep 30, 2018 -20.25%
Jun 30, 2018 15.24%
Mar 31, 2018 100.69%
Dec 31, 2017 41.96%
Sep 30, 2017 36.16%
Jun 30, 2017 -27.87%
Mar 31, 2017 88.04%
Dec 31, 2016 11.49%
Sep 30, 2016 91.67%
Jun 30, 2016 46.08%
Mar 31, 2016 -19.50%
Dec 31, 2015 44.61%
Sep 30, 2015 622.30%
Jun 30, 2015 74.24%
Mar 31, 2015 -5.33%
Dec 31, 2014 81.09%
Sep 30, 2014 76.69%
Jun 30, 2014 128.18%
Mar 31, 2014 91.83%
Dec 31, 2013 107.21%
Sep 30, 2013 -16.97%
Jun 30, 2013 134.02%
Mar 31, 2013 122.43%
Dec 31, 2012 58.85%
Sep 30, 2012 37.64%